Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

NCT01002248 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Perifosine
DRUG: Perifosine Placebo
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

AEterna Zentaris

Collaborators

[object Object]